News

How to Get Fit Fast

How to Get Fit Fast is a new Channel 4 series presented by Amar Latif, the blind entrepreneur and Founder and Director of Traveleyes, the world’s first tour operator offering worldwide …

Precision CRISPR repairs blindness in mice

In genome-editing, the challenge for CRISPR-wielding scientists is to edit only one of the two copies, or alleles, of every gene that people have, repairing the ever-so-slightly broken one and …

Gene therapy company receives Rare Paediatric Disease Designation for the treatment of Achromatopsia

MeiraGTx, a London and New York-based gene therapy company, has announced that the Offices of Orphan Products Development and Pediatric Therapeutics of the U.S. Food and Drug Administration (FDA) have …

Blood-Retina Chip research

Researchers from Microelectronics Institute of Barcelona, Vall d’Hebron Research Institute, and Universitat Autònoma de Barcelona have developed a microfluidic chip that mimics the human blood-retinal barrier in the eye. The …

London opera singer with RP to appear as first blind female TV Judge

Lizzie Capener, a gifted opera singer will be the first blind female TV judge; she appears in the show, All Together Now, which has been described as a “singing contest …

Blind – A sixth Sense art exhibition

We’re pleased to share details of an exhibition that’s taking place in February showcasing the sculptures of a visually impaired artist. Victoria Claire is a Kent-based artist, specialising in contemporary …

GenSight to start clinical testing combination of gene therapy and wearable device

GenSight will start a clinical trial in the UK testing a combination of gene therapy and a wearable device to restore sight in patients with retinitis pigmentosa. The UK Medicines …

Agreement formed for development of AAV vectors for ocular gene therapy

Sirion Biotech GmbH, a virus-based technology and gene delivery company, announced that it has signed a two-year development agreement with Acucela, a clinical-stage ophthalmology company. Recombinant adeno associated virus (rAAV) …

RP Fighting Blindness Membership

We’d like to say a big thank you to everyone who plans to continue supporting RP Fighting Blindness in 2018 as a member. The membership subscriptions are a vital addition …

FDA approves Luxturna gene therapy treatment

The U.S. Food and Drug Administration has approved Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult patients with an inherited form of vision loss that may …

jCyte Presents Results of Clinical Testing in RP

Cell therapy company jCyte has announced results from a phase 1/2a clinical trial for its investigational product, jCell, in retinitis pigmentosa. Presented by David S. Boyer, MD, at the annual …

Scientists explore how a pain medicine also protects vision in blinding conditions

Scientists have shown that a medicine prescribed for severe pain can help preserve vision in a model of severe, blinding retinal degeneration. Now they want to know more about how …